Align Technology (ALGN) Receives Daily News Impact Rating of 0.11

Headlines about Align Technology (NASDAQ:ALGN) have trended somewhat positive recently, according to Accern Sentiment. The research group scores the sentiment of media coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Align Technology earned a media sentiment score of 0.11 on Accern’s scale. Accern also gave news stories about the medical equipment provider an impact score of 46.5340608733472 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

These are some of the media headlines that may have impacted Accern’s scoring:

Align Technology (ALGN) traded up $7.77 on Friday, reaching $241.07. The company’s stock had a trading volume of 1,519,800 shares, compared to its average volume of 1,140,000. The stock has a market cap of $19,330.00, a P/E ratio of 73.27, a PEG ratio of 1.89 and a beta of 1.43. Align Technology has a 12-month low of $88.56 and a 12-month high of $266.41.

Align Technology (NASDAQ:ALGN) last posted its quarterly earnings data on Thursday, October 26th. The medical equipment provider reported $1.01 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.82 by $0.19. The firm had revenue of $385.30 million during the quarter, compared to the consensus estimate of $359.80 million. Align Technology had a return on equity of 25.60% and a net margin of 19.98%. The firm’s revenue was up 38.3% compared to the same quarter last year. During the same period in the prior year, the business earned $0.63 EPS. equities research analysts predict that Align Technology will post 3.65 EPS for the current year.

Several analysts have recently weighed in on the company. Stifel Nicolaus boosted their target price on Align Technology from $245.00 to $265.00 and gave the company a “buy” rating in a report on Tuesday, November 21st. Credit Suisse Group boosted their target price on Align Technology from $175.00 to $209.00 and gave the company an “outperform” rating in a report on Friday, October 27th. Robert W. Baird reissued a “buy” rating and issued a $245.00 target price on shares of Align Technology in a report on Friday, October 27th. Piper Jaffray Companies reissued a “buy” rating and issued a $200.00 target price on shares of Align Technology in a report on Monday, September 11th. Finally, Leerink Swann reissued an “outperform” rating and issued a $250.00 target price on shares of Align Technology in a report on Friday, October 27th. Two analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. Align Technology presently has an average rating of “Buy” and a consensus price target of $236.75.

In other news, CMO Raphael Pascaud sold 5,400 shares of the stock in a transaction that occurred on Friday, November 3rd. The stock was sold at an average price of $241.88, for a total transaction of $1,306,152.00. Following the completion of the transaction, the chief marketing officer now directly owns 22,228 shares of the company’s stock, valued at approximately $5,376,508.64. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Greg J. Santora sold 7,700 shares of the stock in a transaction that occurred on Tuesday, October 31st. The stock was sold at an average price of $238.95, for a total value of $1,839,915.00. The disclosure for this sale can be found here. Over the last three months, insiders have sold 52,849 shares of company stock valued at $13,494,348. Company insiders own 1.60% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Align Technology (ALGN) Receives Daily News Impact Rating of 0.11” was first posted by Community Financial News and is owned by of Community Financial News. If you are accessing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. and international trademark and copyright law. The legal version of this piece of content can be viewed at https://www.com-unik.info/2018/01/07/align-technology-algn-receives-daily-news-impact-rating-of-0-11.html.

Align Technology Company Profile

Align Technology, Inc designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment.

Insider Buying and Selling by Quarter for Align Technology (NASDAQ:ALGN)

What are top analysts saying about Align Technology? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Align Technology and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit